FNY Investment Advisers »

Terns Pharmaceuticals shares owned by FNY Investment Advisers

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by FNY Investment Advisers from 13F filings

Historical chart of FNY Investment Advisers investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by FNY Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by FNY Investment Advisers

Quarter filed Position value Share count Share price at filing
2025-12-31 $80k 2.0k 40.00

More positions owned by FNY Investment Advisers

Cidara Therapeutics (CDTX)
Bank Of Montreal Cadcom (BMO)
Amplify Etf Tr (SILJ)
UnitedHealth (UNH)
Global X Fds global x copper (COPX)
Monolithic Power Systems (MPWR)
Morgan Stanley (MS)
Codere Online Luxembourg Ord (CDRO)
NVIDIA Corporation (NVDA)
Vaneck Vectors Gold Miners mutual (GDX)
Philip Morris International (PM)
Bleichroeder Acquisition Cor (BACQ)
Deere & Company (DE)
Futurecrest Acquisition Corp
Norfolk Southern (NSC)

View all positions for FNY Investment Advisers

Top funds holding Terns Pharmaceuticals

Soleus Capital Management
OrbiMed Advisors
Deep Track Capital
Vivo Capital
Commodore Capital
BlackRock
Vanguard Group
Adage Capital Partners GP
Candriam Luxembourg S.C.A.
Acorn Capital Advisors
Schonfeld Strategic Advisors
Geode Capital Management
Citadel Advisors
State Street Corporation
Pictet Asset Management Holding SA

View all funds holding Terns Pharmaceuticals